The cellular switch from normal astrocytes to neoplastic GBM cells is associated with a drastic reduction in the OS and a worse prognosis in the GBM patients who lose both the TRPML1 and TRPML2 channels (Figure 9). The gene discussed is MCOLN2; the disease is glioblastoma.